ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Fermilab Treats 1,000th Patient

August 7, 1981

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

Ann Landers, Columnist Who Urged Support for Cancer Act, Dead

June 28, 2002

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013